Navigation Links
Sharron Davies opens new respiratory research clinic
Date:6/10/2010

Olympic swimmer and television personality Sharron Davies MBE was in Nottingham this week to open a new clinical trials unit that will take treatments for respiratory illnesses such as asthma from laboratory bench to bedside.

The Nottingham Respiratory BRU Clinical Trials Unit will bridge the gap between treatment and research by offering clinical services to NHS patients with respiratory disease, while recruiting volunteers for studies into developing new drugs and therapies to help people to manage their illness.

The new centre is part of the Nottingham Respiratory Biomedical Research Unit (NRBRU), a partnership between The University of Nottingham and Nottingham University Hospitals NHS Trust.

Funded with 6.1 million by the Department of Health's National Institute for Health Research, it is one of 16 Biomedical Research Units in the UK focusing on 'translational research' taking advances and innovations in basic medical research out of the laboratory and into NHS practice, with the ultimate aim of improving patient care.

Sharron Davies unveiled the new unit, based at the Nottingham City Hospital campus on Wednesday June 9.

She said: "I am delighted to have been invited to open the new Nottingham Respiratory BRU Clinical Trials Unit. Asthma is a serious disease and a health issue that many competitive swimmers have to overcome to achieve success in their sport. It is exciting to think that the clinical trials that will be conducted in Nottingham could one day make a real difference to the millions of people worldwide who suffer from this debilitating illness."

The Nottingham Respiratory Biomedical Research Unit brings together 10 research groups carrying out biomedical, epidemiological and clinical respiratory research. The new clinical trials unit will be based within Nottingham City Hospital in space previously occupied by the paediatric outpatient facility before it was moved to the new Nottingham Children's Hospital at the Queen's Medical Centre campus.

Director of the NRBRU Professor Alan Knox said: "The new unit will bring together both the clinical and research strands of our work to provide a great facility to test new medicines for asthma and COPD. Recruiting for clinical trials is a great example of how the local community in Nottingham can help to make a positive impact on the future health of the city and its inhabitants."

Among the research being carried out at the NRBRU that will benefit from the new clinical trials unit is a study being led by Dr John Anderson looking whether a tablet originally produced for people with diabetes could be used to treat mild asthma.

Dr Anderson said: "Studies like ours rely on the goodwill of patients who give up their time, often for no monetary reward, to help develop our understanding of respiratory conditions such as asthma and to explore new options for treatments.

"We have found that although, it may not benefit their own health in the short term, patients are often keen to take part in clinical trials because they like the idea that their involvement could in the future give relief to others who suffer from the same debilitating conditions."


'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-115-951-5793
University of Nottingham
Source:Eurekalert

Related medicine news :

1. McCracken Eye and Face Institute Opens New Office in Lafayette, CO
2. my PC Techs Opens New Technology Solutions Office in Ahwatukee
3. Bella Medspa Opens Full Service Office in Lancaster, PA
4. New Aspen Dental Office Opens in Lincoln, Nebraska
5. Village at Proprietors Green Opens on South Shore, Introducing Innovative Senior Living to Boston Area
6. Swanson Health Products Opens East Coast Distribution Center
7. New Aspen Dental Office Opens in Grand Island, Nebraska
8. Renal Advantage Inc. (RAI) has Solid Growth, Opens 6 New Centers in 4 Months
9. Prominent East Tennessee Law Firm Opens Greene County Office
10. New Varicose Vein Treatment Center Opens in Prescott, Arizona
11. Mosquito Squad Opens New Location in Marietta, Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... An ... permit amputees to safely ride all types of amusement park rides. , The patent-pending ... the unit is easy to use and could be set up in a matter ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pennsylvania Cable Network (PCN) during the summer of 2016. The program was made ... by the United States Department of Health and Human Services Administration. The ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate that ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... KEY FINDINGS North America ... market in 2016 and is expected to continue in ... a large number of surgical procedures that are taking ... in the patient temperature management market.) Patient warming and ... of blood during surgeries, lowering the risks of neurological ...
(Date:12/8/2016)... , Dec 8, 2016 Research and ... Market Analysis and Trends - Adhesion Type, Application, Usability - Forecast ... ... Global Cardiology Electrodes Market is poised to grow at a CAGR ... trends that the market is witnessing include advancements in extracellular microelectrode ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology: